High Fecal Carriage of Extended-Spectrum β-Lactamase Producing Enterobacteriaceae by Children Admitted to the Pediatric University Hospital Complex in Bangui, Central African Republic
Authors:
- Hugues Sanke-WaïganaHSHugues Sanke-Waïgana
- Cheikh FallCFCheikh Fall
- Jean-Chrysostome GodyJGJean-Chrysostome Gody
- Eliot Kosh KombaEKEliot Kosh Komba
- Gilles NgayaGNGilles Ngaya
- Jean-Robert MbeckoJMJean-Robert Mbecko
- Brice Martial YambiyoBYBrice Martial Yambiyo
- Alexandre ManirakizaAMAlexandre Manirakiza
- Guy VernetGVGuy Vernet
- Alioune DieyeADAlioune Dieye
- Yakhya DieyeYDYakhya Dieye
Open Access
Abstract
Antimicrobial resistance (AMR) is a global public health threat. Quality data on AMR are needed to tackle the rise of multidrug-resistant clones. These data are rare in low-income countries, especially in sub-Saharan Africa. In this study, we investigated the rise of extended-spectrum β-lactamase–producing (ESBL) Enterobacteriaceae in Bangui, Central African Republic. We collected 278 fecal samples from 0–5-year-old children admitted to the Pediatric University Hospital Complex in Bangui from July to September 2021. Enterobacteriaceae were isolated and identified, and their susceptibility to 19 antibiotics was tested. We recovered one and two Enterobacteriaceae species from 208 and 29 samples, respectively. One clone of each species from each sample was further characterized, for a total of 266 isolates. Escherichia coli predominated, followed by Klebsiella. AMR was frequent, with 98.5% (262/266) of the isolates resistant to at least one antibiotic. Additionally, 89.5% (238/266) of the isolates were multidrug resistant, with resistance being frequent against all tested antibiotics except carbapenems and tigecycline, for which no resistance was found. Importantly, 71.2% (198/278) of the children carried at least one ESBL species, and 85.3% (227/266) of the isolates displayed this phenotype. This study confirms the rise of ESBL Enterobacteriaceae in Bangui and stresses the need for action to preserve the efficacy of antibiotics, as crucial for the treatment of bacterial infections.Keywords
Funding Information
- Institut Pasteur of Bangui
- Department of Cooperation and Cultural Action of the French Embassy in Bangui
- Department of International Network Affairs of the Institut Pasteur of Paris
This publication has 29 references indexed in Scilit:
- β-Lactams and β-Lactamase Inhibitors: An OverviewCold Spring Harbor Perspectives in Medicine, 2016
- A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of EnzymesClinical Microbiology Reviews, 2016
- Characterization of ESBL disseminating plasmidsInfectious Diseases, 2015
- Burden of bacterial resistance among neonatal infections in low income countries: how convincing is the epidemiological evidence?BMC Infectious Diseases, 2015
- Antimicrobial-resistant Enterobacteriaceae from humans and wildlife in Dzanga-Sangha Protected Area, Central African RepublicVeterinary Microbiology, 2014
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genesInfection and Drug Resistance, 2014
- Trends in Human Fecal Carriage of Extended-Spectrum β-Lactamases in the Community: Toward the Globalization of CTX-MClinical Microbiology Reviews, 2013
- Updated Functional Classification of β-LactamasesAntimicrobial Agents and Chemotherapy, 2010
- Increasing prevalence of antimicrobial resistance among Enterobacteriaceae uropathogens in Bangui, Central African RepublicThe Journal of Infection in Developing Countries, 2009
- Extended-spectrum plasmid-mediated -lactamasesJournal of Antimicrobial Chemotherapy, 1995